Similarly, in another study, transferrin-targeted siRNA nanoparticles did not show an increase in tumour accumulation but resulted in a ~ 50% decrease in tumour growth compared to non-targeted nanoparticles due to increased cellular uptake [37]. The gene discussed is TF; the disease is neoplasm.